IS4611A - Aðferð til að auka hraða blóðstreymis um hornhimnu og sjóntaugar-ós til að viðhalda sjón - Google Patents

Aðferð til að auka hraða blóðstreymis um hornhimnu og sjóntaugar-ós til að viðhalda sjón

Info

Publication number
IS4611A
IS4611A IS4611A IS4611A IS4611A IS 4611 A IS4611 A IS 4611A IS 4611 A IS4611 A IS 4611A IS 4611 A IS4611 A IS 4611A IS 4611 A IS4611 A IS 4611A
Authority
IS
Iceland
Prior art keywords
cornea
blood flow
optic nerve
increase blood
maintain vision
Prior art date
Application number
IS4611A
Other languages
English (en)
Inventor
Eric Sponsel William
Harris Alon
Original Assignee
Advanced Research And Technology Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Research And Technology Institute filed Critical Advanced Research And Technology Institute
Publication of IS4611A publication Critical patent/IS4611A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS4611A 1995-05-22 1997-11-10 Aðferð til að auka hraða blóðstreymis um hornhimnu og sjóntaugar-ós til að viðhalda sjón IS4611A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/445,839 US5789435A (en) 1995-05-22 1995-05-22 Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight
PCT/US1996/007225 WO1996037203A1 (en) 1995-05-22 1996-05-17 Method to increase retinal blood flow

Publications (1)

Publication Number Publication Date
IS4611A true IS4611A (is) 1997-11-10

Family

ID=23770397

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4611A IS4611A (is) 1995-05-22 1997-11-10 Aðferð til að auka hraða blóðstreymis um hornhimnu og sjóntaugar-ós til að viðhalda sjón

Country Status (21)

Country Link
US (1) US5789435A (is)
EP (1) EP0833632A1 (is)
JP (1) JPH11503462A (is)
KR (1) KR19990021853A (is)
CN (1) CN1186019C (is)
AU (1) AU703301B2 (is)
BG (1) BG63148B1 (is)
BR (1) BR9609297A (is)
CA (1) CA2218549C (is)
CZ (1) CZ289224B6 (is)
EE (1) EE9700361A (is)
HK (1) HK1020166A1 (is)
HU (1) HUP9802553A3 (is)
IS (1) IS4611A (is)
NO (1) NO318600B1 (is)
NZ (1) NZ308016A (is)
RU (1) RU2181045C2 (is)
SK (1) SK283960B6 (is)
TR (1) TR199701406T1 (is)
UA (1) UA48178C2 (is)
WO (1) WO1996037203A1 (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294343A1 (en) * 1997-06-26 1999-01-07 Merck & Co., Inc. Method for optimizing retinal and optic nerve health
US6126037A (en) * 1997-09-09 2000-10-03 Merck & Co., Inc. Flow control orifice
WO1999030717A1 (en) * 1997-12-12 1999-06-24 Alcon Laboratories, Inc. Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow
WO1999037292A2 (en) * 1998-01-23 1999-07-29 Merck Sharp & Dohme B.V. Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
WO1999044603A1 (en) * 1998-03-06 1999-09-10 Sponsel William E Composition and method for treating macular disorders
WO2004073708A1 (en) 1998-12-17 2004-09-02 Dean Thomas R Brinzolamide and brimonidine for treating ocular conditions
JP4717996B2 (ja) * 2000-10-11 2011-07-06 サーパス工業株式会社 容器及びそれに用いるプラグ
US20040046934A1 (en) * 2002-02-14 2004-03-11 Board Of Regents, The University Of Texas System Oculokinetic offset acuity testing
US20040242457A1 (en) * 2003-05-27 2004-12-02 Ashby Charles R. Use of anti-glaucoma drugs to treat visual defects associated with the use of a GABAergic agent
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
MX2007011165A (es) * 2007-09-12 2009-03-11 Arturo Jimenez Bayardo Composición farmacéutica estable de timolol, dorzolamida y brimonidina.
US10363245B2 (en) 2017-02-22 2019-07-30 The Board Of Regents Of The University Of Texas System Methods for treating CNS lesions
US11787932B2 (en) 2017-12-03 2023-10-17 Natureworks Llc Polylactic resin compositions for paperboard coating and paperboard coating processes using the compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416890A (en) * 1981-07-13 1983-11-22 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4386098A (en) * 1981-11-03 1983-05-31 Merck & Co., Inc. 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
US4426388A (en) * 1982-04-02 1984-01-17 Merck & Co., Inc. 5-Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent

Also Published As

Publication number Publication date
NO318600B1 (no) 2005-04-18
MX9709063A (es) 1998-10-31
CN1199336A (zh) 1998-11-18
US5789435A (en) 1998-08-04
CA2218549C (en) 2005-09-20
WO1996037203A1 (en) 1996-11-28
HUP9802553A2 (hu) 1999-04-28
SK153597A3 (en) 1998-07-08
CZ369497A3 (cs) 1998-06-17
SK283960B6 (sk) 2004-06-08
TR199701406T1 (xx) 1998-03-21
HK1020166A1 (en) 2000-03-31
CA2218549A1 (en) 1996-11-28
BR9609297A (pt) 1999-08-17
CZ289224B6 (cs) 2001-12-12
NO975330L (no) 1998-01-07
CN1186019C (zh) 2005-01-26
JPH11503462A (ja) 1999-03-26
BG63148B1 (bg) 2001-05-31
NO975330D0 (no) 1997-11-20
NZ308016A (en) 2000-09-29
AU5754096A (en) 1996-12-11
EP0833632A1 (en) 1998-04-08
EE9700361A (et) 1998-06-15
EP0833632A4 (is) 1998-05-20
UA48178C2 (uk) 2002-08-15
BG102064A (en) 1998-07-31
HUP9802553A3 (en) 2002-01-28
RU2181045C2 (ru) 2002-04-10
AU703301B2 (en) 1999-03-25
KR19990021853A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
IS4611A (is) Aðferð til að auka hraða blóðstreymis um hornhimnu og sjóntaugar-ós til að viðhalda sjón
DE69627188D1 (de) Brille und brillenfassung
LV12038A (lv) Panemieni un lidzekli cilveka seksualas reakcijas modulesanai
BR9402201A (pt) Solução oftálmica e método para tratar o olho contra irritação e secura
ZA966319B (en) Corneal irrigation cannula
IT1233108B (it) Dispositivo per la correzione delle anomalie di rifrazione dell'occhio.
DK0745396T3 (da) Blodpumpe og anvendelse deraf
DE69321091D1 (de) Demultiplexer und optisches Kommunikationssystem das den Demultiplexer verwendet
DK0801534T3 (da) Forbedret visualisering af koroidal blodstrømning og abnorme vaskulære strukturer i øjet
EP1024810A4 (en) METHOD FOR OPTIMIZING RETINAL AND THE HEALTH OF THE OPTICAL NERVE
DE69620088D1 (de) Blutdruckmessgerät
FI943182A0 (fi) Silmän verenpainetta alentava aine
NZ291053A (en) Method to maximise the health of the optic nerve and retina by using a beta-adrenergic blocking agent
FR2718254B1 (fr) Lunettes, notamment de vue ou solaires, et monture s'y rapportant.
KR970008474U (ko) 샤프심통
IS4278A (is) Aðferð til að örva blóðfrumumyndun með blóðrauða
RU95111665A (ru) Способ фиксации составного мостовидного протеза
KR970011600U (ko) 보안경
ITUD950048A0 (it) Occhiali protettivi
IT1298215B1 (it) Metodo educativo per superare la dislessia collegata a predominanza dell'occhio sinistro (mancinismo oculare) e sussidio ottico per
ITRM920831A1 (it) Procedimento per trattare superficialmente protesi oculari in vetro.
KR970029532U (ko) 사이드 비저의 리테이너
KR970048256U (ko) 보안경 일체형 모니터
KR960032345U (ko) 안경,보안경테를 이용한 보조렌즈 착탈사용
ITVI950123A0 (it) Procedimento computerizzato biomedicale